Open AccessTechnique of Xen Implant Revision Surgery and the Surgical Outcomes: A Retrospective Interventional Case Series
Author(s) -
Emma Linton,
Leon Au
Publication year - 2020
Publication title -
ophthalmology and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.189
H-Index - 17
eISSN - 2193-6528
pISSN - 2193-8245
DOI - 10.1007/s40123-020-00234-0
Subject(s) - medicine , surgery , glaucoma , trabeculectomy , stent , implant , medical record , glaucoma surgery , retrospective cohort study , intraocular pressure , ophthalmology
The Xen® Gel Stent (Allergan, Irvine, CA, USA) is a minimally invasive glaucoma surgery device implanted to reduce intra-ocular pressure (IOP) in glaucoma. The stents can fail to drain post-operatively due to scarring of the conjunctiva around the stent opening. Data on the success rates of revision surgery in patients with Xen stent failure are scarce. We present the first detailed report of the steps, outcomes and complications of Xen revision surgery with 12 months of follow-up data.